Rilzabrutinib
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Rilzabrutinib, covering 2024-03-07 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Results: Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine [Phase 2]